Madalina Elena Petran

Dr. Madalina Elena Petran

"Carol Davila" University of Medicine and Pharmacy,, Bucharest, Bucureşti, Romania
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Argyrios PeriferakisArgyrios Periferakis
Argyrios Periferakis
KPKonstantinos Periferakis
Konstantinos Periferakis
IBIoana Anca Badarau
Ioana Anca Badarau
MPMadalina Elena Petran
Madalina Elena Petran
DPDelia Codruta Popa
Delia Codruta Popa
Daniel Octavian CostacheDaniel Octavian Costache
Daniel Octavian Costache
Flavonoids are a category of plant-derived compounds which exhibit a large number of health-related effects. One of the most well-known and studied flavonoids is kaempferol, which can be found in a wide variety of herbs and plant families. Apart from their anticarcinogenic and anti-inflammatory effects, kaempferol and its associated compounds also exhibit antibacterial, antifungal, and antiprotozoal activities. The development of drugs and treatment schemes based on these compounds is becoming increasingly important in the face of emerging resistance of numerous pathogens as well as complex molecular interactions between various drug therapies. In addition, many of the kaempferol-containing plants are used in traditional systems all over the world for centuries to treat numerous conditions. Due to its variety of sources and associated compounds, some molecular mechanisms of kaempferol antimicrobial activity are well known while others are still under analysis. This paper thoroughly documents the vegetal and food sources of kaempferol as well as the most recent and significant studies regarding its antimicrobial applications.

Verified
Journal Article
Open access
PDF file
MPMadalina Elena Petran
Madalina Elena Petran
Argyrios PeriferakisArgyrios Periferakis
Argyrios Periferakis
Lamprini TroumpataLamprini Troumpata
Lamprini Troumpata
APAristodemos-Theodoros Periferakis
Aristodemos-Theodoros Periferakis
ASAndreea-Elena Scheau
Andreea-Elena Scheau
Cristian ScheauCristian Scheau
Cristian Scheau
Capsaicin, the most prominent pungent compound of chilli peppers, has been used in traditional medicine systems for centuries; it already has a number of established clinical and industrial applications. Capsaicin is known to act through the TRPV1 receptor, which exists in various tissues; capsaicin is hepatically metabolised, having a half-life correlated with the method of application. Research on various applications of capsaicin in different formulations is still ongoing. Thus, local capsaicin applications have a pronounced anti-inflammatory effect, while systemic applications have a multitude of different effects because their increased lipophilic character ensures their augmented bioavailability. Furthermore, various teams have documented capsaicin’s anti-cancer effects, proven both in vivo and in vitro designs. A notable constraint in the therapeutic effects of capsaicin is its increased toxicity, especially in sensitive tissues. Regarding the traditional applications of capsaicin, apart from all the effects recorded as medicinal effects, the application of capsaicin in acupuncture points has been demonstrated to be effective and the combination of acupuncture and capsaicin warrants further research. Finally, capsaicin has demonstrated antimicrobial effects, which can supplement its anti-inflammatory and anti-carcinogenic actions.

12 January 2022 in Frontiers in Pharmacology
Verified
Journal Article
Open access
TGTeodora-Cristiana Gradinaru
Teodora-Cristiana Gradinaru
MPMadalina Elena Petran
Madalina Elena Petran
DDDorin Dragoş
Dorin Dragoş
MGMarilena Gilca
Marilena Gilca
PlantMolecularTasteDB: A Database of Taste Active Phytochemicals

6 November 2022 in Plants
Verified
Journal Article
Open access
PDF file
DDDorin Dragoş
Dorin Dragoş
MPMadalina Elena Petran
Madalina Elena Petran
TGTeodora Gradinaru
Teodora Gradinaru
MGMarilena Gilca
Marilena Gilca
The taste of a herb influences its use in traditional medicine. A molecular basis for the taste-based patterns ruling the distribution of herbal (ethno) pharmacological activities may not be excluded. This study investigated the potential correlations between the anti-inflammatory activity (AIA) and the phytocompound taste and/or its chemical class. The study relies on information gathered by an extensive literature (articles, books, databases) search and made public as PlantMolecularTasteDB. Out of a total of 1527 phytotastants with reliably documented taste and structure available in PlantMolecularTasteDB, 592 (for each of which at least 40 hits were found on PubMed searches) were included in the statistical analysis. A list of 1836 putative molecular targets of these phytotastants was afterwards generated with SwissTargetPrediction tool. These targets were systematically evaluated for their potential role in inflammation using an international databases search. The correlations between phytochemical taste and AIA, between chemical class and AIA, and between the taste and the number of inflammation related targets were statistically analyzed. Phytochemical taste may be a better predictor of AIA than the chemical class. Bitter phytocompounds have a higher probability of exerting AIA when compared with otherwise phytotastants. Moreover, bitter phytotastants act upon more inflammation related targets than non-bitter tasting compounds.

16 June 2025 in Microorganisms
Verified
Journal Article
Open access
PDF file
GNGabriela Viorela Nitescu
Gabriela Viorela Nitescu
DUDiana Andreea Usurelu
Diana Andreea Usurelu
TOTeodora Olsavszky
Teodora Olsavszky
AMAna-Maria Mihalcea
Ana-Maria Mihalcea
APAndra Postelnicu
Andra Postelnicu
CUCoriolan Emil Ulmeanu
Coriolan Emil Ulmeanu
Multisystemic inflammatory syndrome in children (MIS-C) is a rare but potentially severe condition that affects multiple organ systems. This study aimed to assess the clinical characteristics and outcomes of patients diagnosed with multisystemic inflammatory syndrome in children (MIS-C) associated with COVID-19. A 12-month prospective study was conducted at the “Grigore Alexandrescu” Clinical Emergency Hospital for Children, Bucharest. This study included children aged 0–18 years who were diagnosed with MIS-C, as defined by the World Health Organization (WHO), the Royal College of Paediatrics and Child Health (RCPCH), and the Centers for Disease Control and Prevention (CDC) criteria. Data on age, gender, clinical and laboratory findings, treatment, and outcomes were analyzed. Follow-up evaluations occurred at one, three, six, nine, and twelve months post-discharge. Among 36 patients (47.3% female, 52.7% male; mean age, 9.9 years), fever and inflammatory syndrome were present in all patients. Other common symptoms included mucocutaneous (63.8%), gastrointestinal (52.7%), cardiac (47.2%), pulmonary (38.8%), and neurological (11.1%) manifestations. At admission, 14/36 were IgM-positive, while 34/36 were IgG-positive. Follow-up revealed sequelae in two patients, including coronary aneurysms and ground-glass pulmonary opacities. Although MIS-C can be severe, most patients had favorable outcomes with proper treatment. Few long-term, organ-specific complications were observed, highlighting the importance of systematic monitoring to ensure full recovery.